Gallbladder carcinoma is still valid according to Robbins. The textbook also mentions ERBB2 as occasionally being amplified with progression of esophageal adenocarcinoma, but nothing regarding gastric cancer.
amboss and FA 2022 list gastric and breast, approving, can revisit if needed